WALTHAM, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company has submitted a New Drug Application (NDA) to the United States Food and Drug [...]
Modus Outcomes, a scientific research company, will be doing a global survey later this year for the MOSAIC study. The study explores people’s experiences with geographic atrophy (GA), which is also known as advanced dryage-related macular degeneration (AMD). We are [...]
"Research makes medicine" guides our mission to find a cure! We continue to fund groundbreaking research that was started many years ago by the Macula Vision Research Foundation (MVRF). Our mission to save sight for millions with MacD – is [...]
Dawn Prall and Joshua Dunaief discuss AMD Central, a new site for people living with the condition Recently, I talked to Dawn Prall, founder and executive director of The SupportSight Foundation, and Joshua L. Dunaief, Adele Niessen Professor of Ophthalmology [...]
The STEP Program™: Supporting Solutions From Patient Advocacy Organizations Patient advocacy organizations are a key source of information, empowerment, and support for patients at every step of their health care experience, helping them and their families navigate the care they need. [...]
AMDCentral.org provides access to resources for patients and caregivers in one location AMD Central is a collaboration between the American Macular Degeneration Foundation, BrightFocus Foundation, MD Support, Prevent Blindness and The SupportSight Foundation BALA CYNWYD, Penn., March 25, 2021 /PRNewswire/ -- The [...]
Bala Cynwyd, Pa. - It is estimated that 20 million Americans are now living with age-related macular degeneration (AMD) or low vision – yet, many are left in the dark about living with this devasting disease that robs precious eyesight. [...]
Novartis announced today that the US Food and Drug Administration (FDA) approved BEOVU® (brolucizumab-dbll) injection for the treatment of wet age-related macular degeneration (wet AMD). Wet AMD is caused by too much VEGF (vascular endothelial growth factor), a protein which [...]
The Support Sight Foundation is a 501(c)(3) public charity EIN# 83-1475951.The official registration and financial information may be obtained from the PA Department of State PA ID# 115901. Call 800-732-0999. Registration does not imply endorsement. All contributions are tax-deductible to the full extent of the law.
IRS regulations require us to inform you that no goods or services were provided in return for your gift. TSSF is a 501(c)(3) tax exempt organization.
We would be happy to provide you with a current audited financial report upon request. Please allow 1- 7 business days for a response.
Please contact us:
By Mail: 45 E. City Ave # 516, Bala Cynwyd, PA 19004-2621
By Phone: 888-681-8773 or 610-952-3034
By Email: info@supportsight.org
Copyright ©2022 Support Sight Foundation | All Rights Reserved